Which hedge funds own SGMOQ? SANGAMO THERAPEUTICS INC, Q2 2026 13F holders

0 tracked hedge funds disclosed a position in SGMOQ (SANGAMO THERAPEUTICS INC) in their Q2 2026 13F filings, worth $0 in total. 13 exited: Armistice Capital, LLC, Luminus Management LLC, Ikarian Capital, LLC.

0

Holders

Tracked managers whose filing for the quarter reports a long equity position in the security.

0

New this quarter

Holders whose previous filing (at most two quarters earlier) did not report the security.

13

Exited this quarter

Tracked managers whose previous filing reported the security and whose filing for the quarter does not.

$0

Inflow, new holders

Combined value of the positions the new holders reported for the quarter.

$14.9m

Outflow, exits

Combined value the exiting managers reported for the security in their previous filing.

$0

Combined value

Sum of the holders' reported positions in the security.

0.0%

Share of managers holding

Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.